Clinical trial
Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study - Results at 6 and 12 Months From a Retrospective Multi-centric Study
NCT04198103 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia: A Feasibility Study - Results at 6 and 12 Months From a Retrospective Multi-centric Study
- Lead sponsor
- University of Rome Tor Vergata
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 1, 2018
- Completion date
- March 1, 2020
- Enrollment
- 160 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.